Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Emerg Infect Dis ; 19(7): 1111-4, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23764047

ABSTRACT

While studying chronic verruga peruana infections in Peru from 2003, we isolated a novel Bartonella agent, which we propose be named Candidatus Bartonella ancashi. This case reveals the inherent weakness of relying solely on clinical syndromes for diagnosis and underscores the need for a new diagnostic paradigm in developing settings.


Subject(s)
Bartonella Infections/diagnosis , Bartonella/isolation & purification , Bartonella/classification , Bartonella/genetics , Bartonella Infections/microbiology , Child, Preschool , Genes, Bacterial , Humans , Male , Molecular Diagnostic Techniques , Multilocus Sequence Typing , Phylogeny , Sequence Homology, Nucleic Acid
3.
BMC Gastroenterol ; 6: 9, 2006 Feb 25.
Article in English | MEDLINE | ID: mdl-16504135

ABSTRACT

BACKGROUND: Infectious gastrointestinal illness (IGI) outbreaks have been reported in U.S. Navy ships and could potentially have an adverse mission impact. Studies to date have been anecdotal. METHODS: We conducted a retrospective analysis of weekly reported disease and non-battle injury health data collected in 2000-2001 from 44 U.S. Navy ships while sailing in the 5th Fleet (Persian Gulf and nearby seas). RESULTS: During this period, 11 possible IGI outbreaks were identified. Overall, we found 3.3 outbreaks per 100 ship-weeks, a mean outbreak duration of 4.4 weeks, and a mean cumulative ship population attack rate of 3.6%. Morbidity, represented by days lost due to personnel being placed on sick-in-quarters status, was higher during outbreak weeks compared to non-outbreak weeks (p = 0.002). No clear seasonal distribution was identified. CONCLUSION: Explosive outbreaks due to viruses and bacteria with the potential of incapacitating large proportions of the crew raise serious concerns of mission impact and military readiness.


Subject(s)
Disease Outbreaks/statistics & numerical data , Gastrointestinal Diseases/epidemiology , Military Personnel/statistics & numerical data , Ships/statistics & numerical data , Absenteeism , Gastrointestinal Diseases/therapy , Hospitalization/statistics & numerical data , Humans , Indian Ocean , Middle East , Retrospective Studies , United States
4.
Curr Infect Dis Rep ; 7(1): 54-60, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15610672

ABSTRACT

Human African trypanosomiasis has re-emerged as a serious public health threat after near-elimination because of diminished investment in previously successful control programs. The continued, occasional importation of African trypanosomiasis to the United States can be expected as tourists and immigrants travel from high-risk areas. No vaccine or chemoprophylaxis is available for this disease, and travelers to affected areas should be counseled on tsetse fly avoidance. New diagnostic and staging tests are promising but have not replaced the classical method of examining body fluids for trypanosomes. Prompt diagnosis and staging is essential because if untreated, East African and West African sleeping sickness are fatal. Drug regimens are toxic and cumbersome, and short-term prospects for therapeutic advances are limited.

5.
JAMA ; 292(24): 2997-3005, 2004 Dec 22.
Article in English | MEDLINE | ID: mdl-15613668

ABSTRACT

CONTEXT: Acute eosinophilic pneumonia (AEP) is a rare disease of unknown etiology characterized by respiratory failure, radiographic infiltrates, and eosinophilic infiltration of the lung. OBJECTIVES: To describe a case series of AEP, illustrate the clinical features of this syndrome, and report the results of an epidemiologic investigation. DESIGN, SETTING, AND PARTICIPANTS: Epidemiologic investigation of cases of AEP identified both retrospectively and prospectively from March 2003 through March 2004 among US military personnel deployed in or near Iraq. Survivors were offered a follow-up evaluation. MAIN OUTCOME MEASURE: Morbidity and mortality related to AEP. RESULTS: There were 18 cases of AEP identified among 183,000 military personnel deployed in or near Iraq during the study period, yielding an AEP incidence of 9.1 per 100,000 person-years (95% confidence interval, 4.3-13.3). The majority of patients (89%) were men and the median age was 22 (range, 19-47) years. All patients used tobacco, with 78% recently beginning to smoke. All but 1 reported significant exposure to fine airborne sand or dust. Known causes of pulmonary eosinophilia (eg, drug exposures or parasitic disease) were not identified. Epidemiologic investigation revealed no evidence of a common source exposure, temporal or geographic clustering, person-to-person transmission, or an association with recent vaccination. Six patients underwent bronchoalveolar lavage (median eosinophilia of 40.5%). All patients developed peripheral eosinophilia (range, 8%-42%). Mechanical ventilation was required in 67% for a median of 7 (range, 2-16) days. Two soldiers died; the remainder responded to corticosteroids and/or supportive care. Twelve individuals were reevaluated a median of 3 months after diagnosis. At that point, 3 patients reported mild dyspnea and 1 reported wheezing. All patients had finished treatment and had either normal or nearly normal spirometry results. None had recurrent eosinophilia. CONCLUSIONS: AEP occurred at an increased rate among this deployed military population and resulted in 2 deaths. Failure to consider AEP in the differential diagnosis of respiratory failure in military personnel can result in missing this syndrome and possibly death. The etiology of AEP remains unclear, but the association with new-onset smoking suggests a possible link.


Subject(s)
Military Personnel , Pulmonary Eosinophilia/epidemiology , Warfare , Acute Disease , Adult , Female , Humans , Iraq , Male , Middle Aged , Pulmonary Eosinophilia/diagnosis , Pulmonary Eosinophilia/physiopathology , Smoking , Syndrome , Nicotiana , United States
6.
Antimicrob Agents Chemother ; 48(9): 3598-601, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15328137

ABSTRACT

The drug resistance profiles of Plasmodium falciparum isolated from four regions in Kenya were analyzed for drug resistance profiles. We observed variability in resistance to a broad range of antimalarial drugs across Kenya as determined from in vitro drug susceptibility screening and genotyping analysis.


Subject(s)
Antimalarials/pharmacology , Malaria, Falciparum/parasitology , Plasmodium falciparum/drug effects , Plasmodium falciparum/genetics , Animals , Drug Resistance , Genes, Protozoan/genetics , Genotype , Humans , Kenya/epidemiology , Malaria, Falciparum/epidemiology , Molecular Epidemiology , Mutation/genetics , Pharmacoepidemiology
7.
Emerg Infect Dis ; 8(2): 138-44, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11897064

ABSTRACT

In December 1997, 170 hemorrhagic fever-associated deaths were reported in Garissa District, Kenya. Laboratory testing identified evidence of acute Rift Valley fever virus (RVFV). Of the 171 persons enrolled in a cross-sectional study, 31(18%) were anti-RVFV immunoglobulin (Ig) M positive. An age-adjusted IgM antibody prevalence of 14% was estimated for the district. We estimate approximately 27,500 infections occurred in Garissa District, making this the largest recorded outbreak of RVFV in East Africa. In multivariable analysis, contact with sheep body fluids and sheltering livestock in one s home were significantly associated with infection. Direct contact with animals, particularly contact with sheep body fluids, was the most important modifiable risk factor for RVFV infection. Public education during epizootics may reduce human illness and deaths associated with future outbreaks.


Subject(s)
Disease Outbreaks , Orthobunyavirus/isolation & purification , Rift Valley Fever/diagnosis , Rift Valley Fever/epidemiology , Adolescent , Adult , Age Distribution , Antibodies, Viral/blood , Child , Cross-Sectional Studies , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoglobulin M/blood , Kenya/epidemiology , Male , Middle Aged , Orthobunyavirus/immunology , Population Surveillance , Rift Valley Fever/immunology , Risk Factors , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...